This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Catalent France Beinheim Sa, Endotis Pharma. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Vanessa Nancy-Portebois
Introduction
Vanessa Nancy-Portebois is a notable inventor based in Les Pavillons Sous Bois, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. Her innovative work has led to the creation of a unique pharmaceutical formulation that showcases her expertise and dedication to advancing medical science.
Latest Patents
Vanessa holds one patent for a pharmaceutical oral dosage form containing a synthetic oligosaccharide. This invention focuses on a formulation intended for oral administration that includes a synthetic oligosaccharide with therapeutic activity. The formulation comprises various components, including a lipophilic phase, lipophilic and hydrophilic surfactants, and optional hydrophilic solvents. This innovative approach aims to enhance the efficacy and stability of pharmaceutical products.
Career Highlights
Throughout her career, Vanessa has worked with reputable companies in the pharmaceutical industry. Notable among these are Endotis Pharma and Catalent France Beinheim. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in pharmaceutical formulations.
Collaborations
Vanessa has collaborated with esteemed colleagues, including Julien Meissonnier and Nathalie Sicre. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceuticals.
Conclusion
Vanessa Nancy-Portebois exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patented formulation, highlight her commitment to improving healthcare through scientific advancements. Her work continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile